ASRM Applauds Administration Decision to Continue Fetal Tissue Research
Apr 16, 2021
Origin: ASRM Press Release
“The American Society for Reproductive Medicine (ASRM) applauds the decision from the National Institutes of Health (NIH)to continue to allow federally funded researchers to work with tissues and cell lines originally derived from fetal tissue. As we have seen with the development of the COVID-19 vaccines and therapeutics, the impact of these materials as research tools is broad, and essential.
The United States government has developed a robust system of oversight and it important that this system be allowed to work as designed. Ideologically driven politicians must not be allowed to interfere with this system on a whim. Whether its fetal tissue, embryonic stem cells or CRSIPR, we have an unfortunate tendency to politicize scientific advances if they in any way touch on reproduction.”
For a copy of the NIH announcement click here.